Table 3.
|
---|
THE PATIENT’S PERSPECTIVE: SUMMARY KEY POINTS |
|
|
|
To have an early and accurate diagnosis! |
|
What’s necessary? To increase awareness of the disease |
|
Public campaigns (directed to the general population) Sensibilization of media Collaborative work: Amyloidosis support groups for patients, National Cardiology Societies, industry (sponsors) |
|
Disseminate the diagnostic algorithms & Consensus documents and existing recommendations |
|
|
|
To have the facility of genetic testing |
|
To get from his/her doctor full information about the disease (patients & family, and caregivers) |
|
To be followed in centres with experience in managing amyloidosis/Excellence centres (Ecs)* |
|
Straight relationship between Ecs and the physician’s doctor in the community |
|
To get full information about treatment and prognosis, and discussion with the patient about its expectations |
|
* Should include genetic counseling in case of hereditary transthyretin amyloidosis.